| Ki | 
                    - | 
                
                
                    | EC50 | 
                     | 
                
                
                    | IC50 | 
                    0.62±0.01μM(RatAChE),  62.0±0.72μM( RatBCHE),  0.25±0.03μM(HuAChE) | 
                
                
                    | Inhibition | 
                    62.2±1.8%( human AChE-induced Aβ1-40 aggregation),  85.7±2.5%( Cu2+-induced Aβ1-42 aggregation ),  69.1±1.8%( self-induced Aβ1-42 aggregation) | 
                
                
                    | Toxicity | 
                     | 
                
                
                    | ROS(reactive oxygen species) | 
                    0.84 | 
                
                
                    | Metal Chelating | 
                    Cu2+ | 
                
                
                    | BBB(blood-brain barrier) | 
                     | 
                
                
                    | Target Protein | 
                    Butyrylcholinesterase (BChE) | 
                
                
                    | Effects | 
                    Demonstrated significant metal chelating properties,  moderate acetylcholinesterase(AChE) inhibitory and anti-oxidative activity,  and excellent inhibitory effects on self-induced Aβ1-42 aggregation,  Cu2+-induced Ab1-42 aggregation,  human AChE-induced Aβ1-40 aggregation and disassembled Cu2+-induced aggregation of the well-structured Aβ1-42 fibrils. | 
                
                
                    | Research Models | 
                    In PC12 cell ,  in SH-SY5Y cell,  in mice | 
                
                
                    | Ref. Link | 
                     |